Trial intelligence / Profile preview

Maintenance strategy trial of Kaletra monotherapy versus Atripla in virologically suppressed adults with HIV-1

2009-009776-13Phase 2Active

Sponsor
ANRS
Start
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of lopinavir + ritonavir and tenofovir disoproxil fumarate in Human immunodeficiency virus infection type 1 (2 arms), sponsored by ANRS. Started May 2009; status: active.

02

Drugs

lopinavir + ritonavirtenofovir disoproxil fumarate
03

Conditions

Human immunodeficiency virus infection type 1

Beyond the preview

Go deeper on 2009-009776-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-009776-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call